4//SEC Filing
OMEGA PROTEIN CORP 4
Accession 0001209191-15-079293
CIK 0001053650operating
Filed
Nov 9, 7:00 PM ET
Accepted
Nov 10, 4:12 PM ET
Size
14.7 KB
Accession
0001209191-15-079293
Insider Transaction Report
Form 4
Griffin Mark Edward
VP - Research and Development
Transactions
- Exercise/Conversion
Common Stock
2015-11-09$7.07/sh+19,904$140,721→ 105,499 total - Exercise/Conversion
Common Stock
2015-11-06$7.07/sh+535$3,782→ 86,130 total - Sale
Common Stock
2015-11-06$21.50/sh−535$11,503→ 85,595 total - Sale
Common Stock
2015-11-09$21.60/sh−19,904$429,926→ 85,595 total - Exercise/Conversion
Stock Option (right to buy)
2015-11-09−19,904→ 104,561 totalExercise: $7.07From: 2011-12-01Exp: 2020-12-01→ Common Stock (19,904 underlying) - Exercise/Conversion
Stock Option (right to buy)
2015-11-06−535→ 124,465 totalExercise: $7.07From: 2011-12-01Exp: 2020-12-01→ Common Stock (535 underlying)
Footnotes (4)
- [F1]Stock Option exercised and shares sold automatically pursuant to Trading Plan (SEC Rule 10b5-1)
- [F2]Value represents transactions with a weighted average sales price ranging from $21.50 to $21.90.
- [F3]Full information regarding the number of shares purchased or sold at each separate price will be provided by the filer to the Commission staff, the issuer, or a security holder of the issuer upon request.
- [F4]Vests in 1/3 increments commencing on the first anniversary of date of grant. The date of grant was 12/01/2010.
Documents
Issuer
OMEGA PROTEIN CORP
CIK 0001053650
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001053650
Filing Metadata
- Form type
- 4
- Filed
- Nov 9, 7:00 PM ET
- Accepted
- Nov 10, 4:12 PM ET
- Size
- 14.7 KB